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INTRODUCTION
Marital unions between close biological kin are common 
in many populations, especially in South, Central 
and West Asia, and North and sub-Saharan Africa, 
and in migrant communities from those regions now 
resident in Europe, North America and Oceania.[1] 
From a medical genetics perspective, all marriages 
between couples related as second cousins or closer are 
regarded as consanguineous (derived from the Latin con 
sanguineus; i.e. sharing the same blood), and using this 
definition, it has been estimated that at least 10.4% of 
the current world population of 7.0 billion persons are 
consanguineous, with first cousin marriages especially 
popular.[1]
Despite the many investigations that have been 
conducted into the relationship between consanguinity 
and congenital heart disease (CHD), the precise 
nature and significance of the association remains 
unclear. At the most basic level it would be reasonable 
to assume that if a robust relationship could be 
demonstrated, it would be indicative of a causative 
mutation or the faulty expression of one or a number 
of otherwise rare recessive genes present in the 
parents in heterozygous form and adversely affecting 
embryonic and fetal development when homozygous. 
However, many of the more common CHDs appear 
to be genetically heterogeneous, whether diagnosed 
as isolated anomalies or accompanied by other heart 
defects.[2] If common predisposing genes are involved 
in the expression of CHD then, by definition, the 
likelihood of an association with consanguinity would 
be substantially reduced.[1]
The epidemiological data often are ambiguous, and 
although in many instances the results are suggestive 
of an association between consanguinity and CHD, 
they frequently fail to attain statistical significance. 
Several explanations can be advanced for this 
shortcoming, relating respectively to the diagnostic 
methods and disease criteria that are employed, 
the mode of recruitment of study subjects and the 
numbers and types of cases involved, the demographic 
and genetic structures of individual sub-populations 
and communities, and the methods of consanguinity 
assessment used, with the latter two factors especially 
relevant in the context of the Indian subcontinent.
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ABSTRACT
Numerous articles have been published linking consanguineous marriage to an elevated prevalence of congenital 
heart disease, with ventricular septal defects and atrial septal defects the most commonly cited disorders. While 
initially  persuasive, on closer examination many of these studies have fundamental shortcomings in their design 
and in the recruitment of study subjects and controls. Improved matching of cases and controls, to include 
recognition of the long-established community boundaries within which most marriages are contracted, and 
the assessment of consanguinity within specific levels and types of marital union would improve and help to 
focus the study outcomes. At the same time, major discrepancies between studies in their reported prevalence 
and types of congenital heart disease suggest an urgent need for greater standardization in the classification 
and reporting of these disorders.
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DIAGNOSTIC METHODS AND CRITERIA 
FOR CHD IDENTIFICATION
In most studies, CHD has been diagnosed by 
echocardiography and/or cardiac catheterization, 
with a birth prevalence of 4–8/1000 typically cited 
and approximately 90% of CHD reported as being 
multifactorial in origin.[3] However, in a review by 
the American Heart Association Congenital Defects 
Committee endorsed by the American Academy of 
Pediatrics, an overall CHD incidence of 50/1000 births 
was described as conservative, on the grounds that a 
number of commonly occurring defects are routinely 
excluded from prevalence estimates. For example, 
bicuspid aortic valve, which affects 10–20/1000 people 
in the general population and may be associated with 
considerable morbidity and mortality in later life.[4] 
Further, in studies on Israeli neonates, the incidence of 
ventricular septal defects (VSD) alone was 53/1000.[5] 
The scale of the discrepancy in total CHD incidence 
between the generally accepted level of 4–8/1000 
and 50+/1000 live births therefore raises significant 
concerns, and merits detailed attention and explanation.
As a first step it is important to determine exactly 
which types of heart defect are under investigation, 
the methods of ascertainment employed, the defects 
recorded and reported, and  of equal importance 
which types of CHD were not identified or identifiable 
by the study techniques. With just a few exceptions,[5,6] 
a consistent positive association has been reported 
between consanguinity and VSD and atrial septal defects 
(ASD), but both positive and negative associations 
between consanguinity and patent ductus arteriosus, 
atrioventricular septal defect, pulmonary atresia, 
tetralogy of Fallot and other CHDs have been recorded 
in different populations.[7-10]
What is presently unclear is whether these inter-
population differences are real and indicative of 
population-specific patterns of CHD, which in turn 
could be genetic and/or environmental in origin. Or if 
they also reflect variable diagnostic capacities, expertise 
and experience, the case definitions employed in the 
different study centers which have contributed to the 
literature, and whether ICD codes for malformations of 
the cardiac system were routinely applied, and disorders 
were subtyped in terms of embryological timing.
SELECTION AND COMPOSITION OF THE 
STUDY SAMPLE
A second area of concern relates to the composition of the 
study populations included in CHD investigations. While 
neonates only were recruited in a Lebanese study that 
reported a significant association between consanguinity 
and CHD,[9] many other widely cited studies variously 
recruited symptomatic infants, including some with 
chromosomal anomalies such as Down syndrome, 
children of differing ages, and even adults in the 
third and fourth decades of life.[6-8,10-16] Likewise, while 
some studies included control for the potential effects 
of sociodemographic and lifestyle variables, such as 
maternal age and education, socioeconomic status, and 
smoking, and clinical conditions including pre-eclampsia, 
maternal diabetes, and pregnancy-induced hypertension, 
other studies did not.
Age-independent case selection makes rigorous inter-
study comparisons well-nigh impossible, as defects that 
would, or at least could, have been diagnosed shortly after 
birth may have spontaneously corrected early in life. For 
example, in the Israeli study in which no association 
was found between consanguinity and the incidence of 
VSD, the defects detected were asymptomatic and 89% 
closed spontaneously within the first 10 months of life.[5] 
This outcome was confirmed in an associated study on 
preterm neonates which reported 87.5% spontaneous 
closure of VSD by age 6–11 months.[17]
Many of the more seriously affected cases of CHD 
diagnosed in developing countries die in childhood,[18] 
and unless assessed in early infancy they would not be 
included in prevalence statistics. By comparison, adults 
who are not diagnosed with CHD until their 20s and 30s 
but are included in prevalence statistics presumably do 
not have an especially life-threatening condition. Their 
inclusion may thus convey an erroneous impression as to 
the nature and clinical severity of the underlying cardiac 
lesions in the population. With these factors in mind, 
the unqualified use of mixed-age study groups in the 
investigation of CHD and the calculation of prevalence 
rates is questionable. More specifically, in the present 
context, is it appropriate to use the results obtained 
with such heterogeneous patient groups to assess the 
influence of consanguinity on CHD prevalence and 
clinical outcomes?
POPULATION STRATIFICATION IN CASE–
CONTROL AND ASSOCIATION STUDIES
To ensure scientific and clinical relevance, case–control 
and association studies rely on the close matching of 
affected persons with other individuals who do not 
exhibit symptoms and have no family history of the 
disorder under investigation. As previously noted, for 
this reason cases and controls are routinely compared 
and matched in terms of age and gender, and with respect 
to variables such as residence and socioeconomic status. 
While this type of matching might be sufficient when 
largely environmental disorders are under investigation, 
when a genetic predisposition or cause is suspected 
it is of obvious importance that matching in terms of 
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inheritance also needs to be ensured.
This requirement is especially important in South Asia 
due to the very marked patterns and levels of population 
stratification. For example, in India, there are numerous 
co-resident ethnicities and religions, some 50,000–60,000 
caste and non-caste communities, and up to 30% uncle–
niece and first cousin marriages reported in the southern 
states of Andhra Pradesh, Karnataka and Tamil Nadu, and 
in southern Maharashtra.[19-22] Similarly, in Pakistan, the 
population is subdivided into ethnic communities and 
biraderi (literally translated as “brotherhoods”), that is, 
traditional social and occupational groupings inherited 
through the male lineage, and with first cousin marriage 
rates of 40–50+% consistently reported in regional and 
national surveys.[23-25] In both countries, the long history of 
marriage within strict community boundaries means that 
significant genetic differentiation predictably would have 
occurred, with some disease mutations unique to specific 
communities. Ongoing studies have suggested that on 
average each human carries 50–100 genetic variants 
that have been implicated in inherited disorders.[26] 
Ample opportunities would therefore have existed for 
major inter-community genetic differentiation during 
the estimated 3000 years since the initial establishment 
of the caste system.
It is the routine failure to control for population 
genetic subdivisions brought about by community 
endogamy that is of greatest significance and concern 
in association studies, including the investigation of 
CHD. Besides the widely recognized geographical, ethnic 
and religious divisions, the genetic effects of caste and 
sub-caste endogamy have been clearly demonstrated in 
India,[22,27,28] and an equivalent role is played by biraderi 
subdivisions in the Muslim populations of India and 
Pakistan.[29-31] Yet, in the selection of cases and controls, 
little attempt appears to have been made to control for 
these differences, despite the clear role of community-
specific founder mutations in many genetic disorders,[1] 
for example, β-thalassemia in the populations of the 
subcontinent.[32,33]
This problematic situation was demonstrated in a 
bibliographic exercise based on information compiled 
from PubMed, using the terms association study, case–
control study and clinical trial as keywords and matching 
of these terms with caste or biraderi and consanguinity.[34] 
Of the 948 association studies published on Indian 
populations, only 4.2% mentioned caste, while for 2030 
case–control studies the comparable figure was 1.9%, 
and for 1381 clinical trials it was 0.5%. The data for 
Pakistan were essentially the same, with just 6.6% of 
association studies, 1.9% of case–control studies and 0.6% 
of clinical trials indicating caste or biraderi affiliations. 
The combined data therefore suggest non-recognition 
or inadvertent avoidance of the central roles played 
by caste and biraderi membership in determining the 
genetic structure of South Asian populations.
Failure to account for the probability of inter-community 
genetic differences means that the results obtained with 
case–control and gene association studies may at least 
in part represent flawed recruitment protocols and 
thus inappropriate investigative design, which could 
explain the notable lack of reproducibility in many 
gene association studies. However, another factor to be 
considered is that because of the highly endogamous 
nature of caste and biraderi lineages, even children 
described as “non-consanguineous” because their 
parents were unrelated prior to marriage may in fact be 
homozygous at a significant proportion of their gene loci.
This phenomenon relates to the deeper ancestral 
heritage of humans and has been clearly demonstrated 
in studies in Asian, European and North American 
populations.[35-38] Even families known not to have 
contracted consanguineous marriages for at least 5–10 
generations exhibit numerous regions of the genome in 
which there are long uninterrupted runs of homozygosity 
that are indicative of close kin unions in much earlier 
generations.[36,37]
ASSESSING THE INFLUENCE OF 
CONSANGUINITY IN CASE–CONTROL 
AND ASSOCIATION STUDIES
The situation with regard to non-recognition of the 
possible influence of intra-familial marriage in case–
control and association studies is actually more extreme, 
with in India consanguinity mentioned in just 1.0%, 
0.2% and <0.1% of association studies, case–control 
studies, and clinical trials, respectively, possibly due 
to  the strict avoidance of unions between biological 
relatives in many communities. But the fact that only 
4.6% of association studies, 4.0% of case–control studies 
and no clinical trials conducted in Pakistan discussed 
the possible genetic effects of consanguinity in a 
country where 40–50+% of all marriages are between 
first cousins can be highly misleading, especially for 
clinicians and researchers who may be unfamiliar 
with the high prevalence of this form of marriage 
and its consequences in terms of increased genomic 
homozygosity.[34]
Even when consanguinity is included as a variable, as 
has been the case in many studies of CHD, the evaluation 
very frequently is reduced to a simple “consanguineous” 
versus “non-consanguineous” dichotomy. In an uncle–
niece or a double first cousin marriage, the couple is 
assumed to have inherited 1/4 of their genes from a 
common ancestor, whereas in first cousin unions the 
assumption is that the couple has inherited 1/8 of their 
genes from a common ancestor, and for a second cousin 
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couple the comparable proportion is 1/32. This means 
that on average the progeny of an uncle–niece or a double 
first cousin marriage will be expected to have inherited 
identical gene copies at 1/8 of all their loci, defined as a 
coefficient of inbreeding F = 0.125. It follows that for first 
cousin progeny, F = 0.0625, that is, 1/16 loci predictably 
are homozygous, whereas for second cousins, F = 0.0156, 
that is, 1/64 of loci are homozygous.[39]
It is unclear and unhelpful why in investigating the 
impact of consanguinity on the prevalence and types 
of CHD, researchers very frequently have opted to 
coalesce three quite distinct levels of consanguinity (F= 
0.0156, 0.0625 and 0.125), representing an eightfold 
average difference in genomic homozygosity, into a 
single ambiguous and ill-defined “consanguineous” 
category. Failure to recruit adequate numbers of cases 
in each specific category of consanguineous union is not 
a sufficient excuse for the adoption of this practice in 
order to attain statistical significance.
It is also important to recognize that the preferred 
types of consanguineous marriages vary between 
communities with, for example, uncle–niece marriages 
commonly contracted in Dravidian Hindu communities 
in South India, whereas first cousins are by far the 
most common form of consanguineous marriage in 
Muslim populations.[40] Also, since in many communities 
consanguinity is a long-established tradition, the effect 
of uninterrupted intra-familial marriages contracted 
in successive generations would have resulted in much 
higher cumulative coefficients of inbreeding than would 
be predicted on the basis of consanguineous marriage 
in a parental generation only.[41]
Perhaps because of these complex and variable factors, 
it was not unexpected that a study conducted on 
consanguineous progeny in Bangalore, the capital of 
Karnataka where uncle–niece and first cousin marriages 
remain popular, was unable to identify a single gene 
of major effect in a clinically heterogeneous cohort 
of patients with CHD.[42] As suggested by the authors, 
the statistical power of follow-up studies could be 
significantly increased by investigating consanguineous 
families in which multiple children have been diagnosed 
with the same form of CHD. However, a complementary 
approach which would enable more genetically 
meaningful comparisons to be drawn would be to 
match cases and controls according to their community 
of origin, rather than simply on the basis of parental 
consanguinity.[1,42]
DISCUSSION
Obviously, there must be some practical limitation in 
the degree to which cases and controls can be matched, 
and control for potential genetic variables is currently 
much more intractable than for environmental or 
sociodemographic factors. At the same time, it should be 
incumbent on authors to avoid claims for their findings 
that are based on unproven and/or questionable study 
designs, particularly when major variables of genetic 
significance, such as caste/biraderi affiliation and the 
specific levels of consanguinity of individual cases 
and controls, have often been effectively ignored or 
inadequately controlled.
In India, the selection of cases and controls matched 
solely on the basis of personal religion is inadequate 
because most members of the Muslim, Christian and 
Buddhist communities are the descendants of converts 
from Hinduism in the recent or relatively recent past, and 
so they would be expected to share significant portions 
of their genomes with sectors of the majority Hindu 
community.[43] Given the approximately 120 generations 
since the establishment of the caste system, the restricted 
numbers of founder individuals in each caste, the effects 
of subsequent caste sub-divisions, and the action of 
genetic drift, the opportunity for genetic differentiation 
and the accumulation of caste-specific mutations would 
have been equivalently large.
From a global perspective, more appropriate subject 
recruitment based on social and demographic realities 
should lead to improved investigative outcomes for 
CHD and other common disorders. This conclusion 
applies not only to South Asia but also to the Middle 
East, Africa and many other regions of the world where 
clan and tribal affiliations should be integral factors in 
the recruitment of cases and controls. At the same time, 
to facilitate credible inter-population comparisons, the 
standardization of diagnostic methods and particularly 
disease classificatory systems needs to be urgently 
addressed, together with improved statistical analysis 
and reporting of findings. Once these basic changes have 
been effected, it should be possible to more accurately 
assess the impact of consanguineous marriage on the 
health of populations in general, and more specifically 
on the prevalence and types of CHD at family and 
community levels.
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